Navigation Links
Vermillion Reports Third Quarter 2012 Results
Date:11/12/2012

streamline the claims process and strengthen our reimbursement results.

"As we wrap-up 2012 and prepare for the new year, we will work towards greater adoption by focusing on reimbursement, physician awareness and market education. Vermillion remains strongly committed to advancing the market adoption of OVA1 as the most sensitive ovarian cancer diagnostic on the market today. As we further develop our ovarian cancer franchise, we plan to expand beyond clinical labs to address the broader market, including hospitals and other points-of-care."

CEO Succession Plan
As previously announced, the company's board has formed a succession committee of independent directors to oversee the process of identifying and selecting a new CEO. It has also retained a leading executive search firm with experience in CEO transitions to advise the board on potential candidates. Gail Page will continue in her role until the new CEO is appointed, and after assisting in the transition, plans to act as a strategic advisor for the company as required by the board of directors.

Conference Call and Webcast
Vermillion will hold a conference call to discuss its third quarter financial results later today, Monday, November 12, 2012 at 4:30 p.m. Eastern time. Management will host the presentation, followed by a question and answer period.

Date: Monday, November 12, 2012
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Dial-In Number: 1-800-736-4610
International: 1-212-231-2900
Conference ID#: 21607929
Webcast: http://edge.media-server.com/m/p/saaeq3ma/lan/en

The conference call will be webcast live and available for replay via the investor section of the company's website at www.vermillion.com.
Please call
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Vermillion Sets Third Quarter 2012 Conference Call for Monday, November 12, 2012 at 4:30 p.m. ET
2. Vermillion to Present at the 2012 Gateway Conference on September 6
3. Vermillion Reports Second Quarter 2012 Results
4. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
5. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
6. Vermillion Announces CEO Succession Plan
7. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
8. Omeros Corporation Reports Third Quarter 2012 Financial Results
9. VirtualScopics Reports 3rd Quarter 2012 Results
10. Neuland Labs Reports Second Quarter Fiscal Year 2013 Financial Results
11. GenVec Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ... Testing Market"  report to their offering. ... ,Major issues pertaining to the UK NAT ... regulatory, demographic, social and technological trends with ...
(Date:5/27/2015)... 2015 Research and ... of the  "2015 Strategies in the Global ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... of the orthopedics market, including forecasts for ... categories. , ,In addition, the report presents ...
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "2015 Strategies in the ... to their offering.       (Logo: ... designed to help current suppliers and potential ... emerging in the French coagulation testing market ...
Breaking Medicine Technology:Global Orthopedics Market Strategies 2015 2United States Hemostasis Diagnostic Testing Market Strategies 2015 2
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company ... has been appointed to the Company,s Board of Directors, ... seven the number of members on the Abaxis board ... Mr. Altman is Senior Advisor of Bain & ...
... May 2, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... subsidiary, Watson Laboratories, Inc., has launched an authorized ... as part of an exclusive agreement with Ortho-McNeil-Janssen ... today.  Concerta is approved for the treatment of ...
Cached Medicine Technology:Abaxis Appoints Vernon Altman to Board of Directors 2Abaxis Appoints Vernon Altman to Board of Directors 3Watson Launches Generic Concerta® 2Watson Launches Generic Concerta® 3
(Date:5/27/2015)... May 27, 2015 In support of ... 2015 issue of the Journal of American Geriatrics Society ... abdominal obesity, Bedford Commons OB-GYN P.A . is ... non-nutritive sweetener-flavored beverages. , To examine the relationship ... comprehensive San Antonio Longitudinal Study of Aging (SALSA) tracked ...
(Date:5/27/2015)... May 27, 2015 The Case ... a partnership to provide CMSA's Career and Knowledge ... collaboration seeks to strengthen the case/care management workforce ... CKP program. The mutually beneficial agreement provides Medix, ... skills of talent in the healthcare, scientific and ...
(Date:5/27/2015)... SAN DIEGO, May 27, 2015 ... the first healthcare provider along the Gulf Coast ... management (CCM). In partnership with MD Revolution, a ... a new program that enables healthcare providers to ... reimbursements. This new, user-friendly program is designed to ...
(Date:5/27/2015)... CompanionDx announced that its ... analysis in personalized cancer therapy: Non-small cell lung cancer ... of Clinical Oncology (ASCO) as part of their annual ... The molecular and clinical data used for the study ... The study reports improved patient outcomes from a preliminary ...
(Date:5/27/2015)... On June 5, Plan B [the ... with LifeSource to host Donate Your Break, a public ... a LifeSource donor coach outside of 116 W. Illinois ... Demand for whole blood units is highest for LifeSource, ... months. LifeSource requires approximately 1,000 donations per day to ...
Breaking Medicine News(10 mins):Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Donate Your Break and Save Lives at the River North Blood Drive 2
... 10 Warner Chilcott plc (Nasdaq: WCRX ) ... lawsuits against Lupin Limited and its wholly owned subsidiary Lupin ... District of Delaware for infringement of Warner Chilcott,s U.S. Patent ... which cover oral contraceptives LOESTRIN 24 FE and FEMCON FE, ...
... to treat major depression. Many antidepressant medications are available, but no ... right for an individual. As a result, for more than half ... can take months to figure out what does. Now, based ... clinicians may be able to accurately predict within a week whether ...
... The University of Miami School of Nursing and Health Studies ... Foundation in the amount of $30,000 to support six students ... program. "Family nurse practitioners have a promising future" said Nilda ... Studies. "The Dr. John T. Macdonald Foundation grant will help ...
... threat, just like swine flu , THURSDAY, Sept 10 (HealthDay News) ... flu poses a real threat this fall, too. , And the ... Then follow it up with an H1N1 swine flu vaccine when ... Thursday from U.S. health officials, who noted that seasonal flu puts ...
... , , , ... and breadth of the H1N1 virus - the upcoming revisit of ... dangerously low preparedness plans within the private sector. "There,s no question ... Kineo Group. "Businesses are navigating a daunting market and obstacles not ...
... PEMBROKE, Bermuda, Sept. 10 Allied ... announced today that Allied,World,s Chief Operating Officer, David Bell, ... Symposium at the Cityplace Conference Center in,Dallas, Texas on ... Entrepreneurial Insurance Symposium is organized by MarketScout, and,the theme ...
Cached Medicine News:Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 2Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 3Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 4Health News:UCLA researchers develop biomarker for rapid relief of major depression 2Health News:UCLA researchers develop biomarker for rapid relief of major depression 3Health News:UM receives grant to support graduate students in the family nurse practitioner program 2Health News:Get Your Vaccine for Seasonal Flu, Experts Urge 2Health News:Get Your Vaccine for Seasonal Flu, Experts Urge 3Health News:H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 2Health News:Allied World's David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 2Health News:Allied World's David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 3
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... lets you sleep on your ... the morning awake with your ... to take on the day. ... and protection, this preservative-free lubricant ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: